Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price was down 7% during mid-day trading on Monday . The stock traded as low as GBX 1.80 ($0.02) and last traded at GBX 1.85 ($0.02). Approximately 391,878 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 1,262,751 shares. The stock had previously closed at GBX 1.99 ($0.03).
Cizzle Biotechnology Price Performance
The business has a fifty day moving average price of GBX 1.97 and a 200 day moving average price of GBX 1.82. The company has a market capitalization of £7.33 million, a price-to-earnings ratio of -185.00 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- How to invest in marijuana stocks in 7 steps
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What Are the FAANG Stocks and Are They Good Investments?
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
